Colgate-Palmolive (CL) is named among the 14 Best Dividend Aristocrats to Invest in Heading into 2026. BofA raised its price target on CL to $90 from $88 with a Buy rating, citing open questions on consumption growth. Jefferies struck a more positive tone on the household and personal care space, but remained cautious on CL due to softer expectations for oral care and slowing demand in premium pet products. In its Q3 2025 earnings report, CL highlighted challenges from consumer uncertainty, tariffs, and high cost inflation, while focusing on its 2030 Strategy and strong global market positions. CL is a global consumer products company with a core focus on oral care, personal care, and home care products. No promotional content included.
Read more at Yahoo Finance: Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook
